Hikma Pharmaceuticals USA Inc.

Feb 18, 2021

Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the National Children's Cancer Society

Jan 13, 2021

Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report

Oct 20, 2020

Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine

Sep 03, 2020

Hikma receives favourable court ruling for its generic Vascepa®

Aug 26, 2020

Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership

May 28, 2020

Hikma launches Dicyclomine Hydrochloride Oral Solution

May 22, 2020

Hikma receives FDA approval for its generic Vascepa®

May 12, 2020

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP

May 11, 2020

Hikma launches employee matching donation campaign to support local US food banks and pantries

May 04, 2020

Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy

Mar 04, 2020

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates